Total skin electron irradiation techniques: A review

Postepy Dermatologii i Alergologii

Volumn 30, Issue 1, 2013, Pages 50-55

  Piotrowski, Tomasz ^a,b   Milecki, Piotr ^a,b   Skórska, Małgorzata ^b   Fundowicz, Dorota ^b  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b GREATER POLAND CANCER CENTRE   (Poland)

Author keywords

Electron radiation; Mycosis fungoides; Radiotherapy; Review of irradiation techniques; Total skin electron irradiation

Indexed keywords

BODY POSITION; ELECTRON ACCELERATOR; ELECTRON RADIATION; ELECTRON THERAPY; HUMAN; IONIZING RADIATION; MYCOSIS FUNGOIDES; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RADIATION ENERGY; REVIEW; SKIN SURFACE; SYSTEMATIC REVIEW; TOTAL SKIN ELECTRON IRRADIATION; TOTAL SKIN ELECTRON THERAPY;

EID: 84874881156     PISSN: 1642395X     EISSN: None     Source Type: Journal    
DOI: 10.5114/pdia.2013.33379     Document Type: Review

References (76)

1. Willemze R, Kerl H, Sterry W, et al. EORTC classification for primary cutaneous lymphomas. A proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer (EORTC). Blood 1997; 90: 354-71.
2. Willemze R, Meijer C. EORTC Classification for primary cutaneous lymphomas: the best guide to good clinical management. Am J Dermatopathol 1999; 21: 265-73. (Pubitemid 29256824)
3. Alibert JLM. Tableau de plan fongoide: Description des maladiesde la peauobserveeal hopital St. Louis, et exposition des meilleures methods suivies pour leurtraitment. Paris, France, Bariorl Aineet Files 1806.
4. Willemze R. Primary cutaneous lymphomas. Curr Opin Oncol 2000; 12: 419-25. (Pubitemid 32268877)
5. Grzanka A, Placek W.Modern diagnostic methods in cutaneous T-cell limphomas. Postep Derm Alergol 2004; 21: 220-5.
6. Goździcka-Józefiak A, Porȩba E, Brȩborowicz J, et al. The use of immunohistochemistry and molecular biology techniques in the diagnosis of mycosis fungoides. Postep Derm Alergol 2003; 20: 73-9.
7. Bao Q, Hrycushko BA, Dugas JP, et al. A technique for pediatric total skin electron irradiation. Radiat Oncol 2012; 7: 40.
8. Fung MA, Murphy MJ, Hoss DM, et al. Practical evaluation and management of cutaneous lymphoma. J Am Acad Dermatol 2002; 46: 325-57. (Pubitemid 34228882)
9. Lanier C, Andre V, Seguin V, et al. Recurrence of Stachybotrys chartarum during mycological and toxicological study of bioaerosols collected in a dairy cattle shed. Ann Agric Environ Med 2012; 19: 61-7.
10. Freiman A, Sasseville D. Treatment of mycosis fungoides: overview. J Cutan Med Surg 2006; 10: 228-33. (Pubitemid 351506635)
11. Trautinger F, Knobler R, Willemze R, et al. EORTC consensus recommendations for the treatment of mycosis fungoides/ Sézary syndrome. Eur J Cancer 2006; 42: 1014-30.
12. Ramsay DL, Halperin PS, Zeleniuch-Jacquotte A. Topical mechlorethamine therapy for early stage mycosis fungoides. J Am Acad Dermatol 1989; 10: 684-91.
13. Zackheim HS, Epstein EH, Crain WR. Topical carmustine (BCNU) for cutaneous T cell lymphoma: a 15-year experience in 143 patients. J Am Acad Dermatol 1990; 22: 802-10. (Pubitemid 20154080)
14. Ramsay DL, Lish KM, Yalowitz CB, et al. Ultraviolet-B phototherapy for early stage cutaneous T-cell lymphoma. Arch Dermatol 1992; 128: 931-3.
15. Resnick KS, Vonderheid EC. Home UV phototherapy of early mycosis fungoides: long-term folow-up observations in thirty- one patients. J Am Acad Dermatol 1993; 79: 73-7. (Pubitemid 23197200)
16. Roenigk HH. Photochemotherapy for mycosis fungoides. Cancer Treat Rep 1979; 63: 669-73.
17. Hoppe RT, Cox RS, Fuks Z, et al. Electron beam therapy for mycosis fungoides: the Stanford University experience. Cancer Treat Rep 1979; 63: 691-700. (Pubitemid 9217599)
18. Sikorska M, Sokołowska-Wojdyło M, Kowalczyk A, Roszkie - wicz J. Effectiveness of interferon alpha in mycosis fungoides therapy. Postep Derm Alergol 2012; 29: 51-5.
19. Olek-Hrab K, Osmola-Mańkowska A, Silny W, et al. Use of UVA1 in the treatment of mycosis fungoides - case report. Postep Derm Alergol 2011; 28: 158-64.
20. Jenerowicz D, Silny W, Dańczak-Pazdrowska A, et al. Environmental factors and allergic diseases. Ann Agric Environ Med 2012; 19: 475-81.
21. Roenigk HH, Kuzel TM, Skoutelis AP, et al. Photochemotherapy alone or combined with interferon alpha-2a in treatment of cutaneous T-cell lymphoma. J Invest Dermatol 1990; 95: 188-205.
22. Kessler JF, Jones SE, Levine N, et al. Isotretinoin and cutaneous helper T-cell lymphoma (mycosis fungoides). Arch Dermatol 1987; 123: 201-4. (Pubitemid 17002489)
23. Thomsen K, Hammar H, Molin L, et al. Retinoids plus PUVA (RePUVA) and PUVA in mycosis fungoides, plaque stage. A report from the Scandinavian Mycosis Fungoides Group. Acta Derm Venereol (Stockh) 1989; 69: 536-8.
24. Kuzel TM, Gilyon K, Springer E, et al. Interferon alfa-2a combined with phototherapy in the treatment of cutaneous T-cell lymphoma. J Natl Cancer Inst 1990; 82: 203-7. (Pubitemid 20079991)
25. Batycka-Baran A, Reich A, Jankowska-Konsur A, Maj J. New trends in the management of mycosis fungoides and Sezary syndrome. Postep Derm Alergol 2009; 26: 41-55.
26. Osmola-Mańkowska A, Silny W, Dańczak-Pazdrowska A, et al. The sun - our friend or foe? Ann Agric Environ Med 2012; 19: 805-9.
27. Śpiewak R. The substantial differences between photoallergic and phototoxic reactions. Ann Agric Environ Med 2012; 19: 888-9.
28. Wojewoda K, Brenner J, Sokołowska-Wojdyło M, Barańska- Rybak W. Treatment of primary cutaneous lymphoma with reference to the latest therapeutic consensus of the Polish Lymphoma Research Group (PLRG). Postep Derm Alergol 2012; 29: 63-8.
29. Jankowska-Konsur A, Maj J, Woźniak Z, Baran E. Angiogenesis assessment in patients with mycosis fungoides. Postep Derm Alergol 2009; 26: 186-9.
30. AAPM report no. 23. Total skin electron therapy: technique and dosimetry. New York: American Institute of Physics, 1987.
31. Jones GW, Hoppe RT, Gladstein E. Electron treatment for cutaneous T-cell lymphoma. Hemat Clin 1995; 9: 1057-76.
32. Karzmark CJ, Loevinger R, Steele RE. A technique for large-field, superficial electron therapy. Radiology 1960; 74: 633-44.
33. Jones GW, Kacinski BM, Wilson LD, et al. Total skin electron radiation in the management of mycosis fungoides: consensus of the European Organization for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Project Group. J Am Acad Dermatol 2002; 47: 364-70.
34. Edelson R. Cutaneous T cell lymphomas-perspective. Ann Intern Med 1975; 83: 548-52.
35. ICRU Report 35. Radiation dosimetry: electron beams with energies beetwen 1 and 50 MeV. Maryland: ICRU Publ 1984.
36. Braams R. Superficial radiation therapy of large skin areas. Dermatologica 1958; 117: 204-14.
37. Meyler T, Blumberg A, Purser P. Total skin electron beam therapy. Cancer 1978; 42: 1171-6.
38. Fraass BA, Robertson PL, Glatstein E. Whole - skin electron treatment: patient skin dose distribution. Radiology 1983; 146: 811-4. (Pubitemid 13194833)
39. Pawlaczyk M, Piotrowski T, Fundowicz D, et al. Napromie - nianie całej skóry wia̧zkami elektronowymi w terapii ziarni - niaka grzybiastego. Przegl Dermatol 2002; 89: 289-95.
40. Piotrowski T, Malicki J. The rotary dual technique for total skin irradiation in the treatment of mycosis fungoides - a descrip- tion of applied method. Rep Pract Oncol Radiother 2006; 11: 29-37. (Pubitemid 44874146)
41. Toossi MTB, Momennezhad M, Hashemi SM. Monte Carlo simulation for Neptun 10 PC medical linear accelerator and calculations of output factor for electron beam. Rep Pract Oncol Radiother 2012; 17: 115-8.
42. Gerbi BJ, Khan FM, Deibel FC, et al. Total skin electron arc irradiation using a reclined patient position. Int J Radiat Oncol Biol Phys 1989; 17: 397-404. (Pubitemid 19203090)
43. Kumar PO, Patel IS. Rotation technique for superficial total body electron beam irradiation. J Natl Med Assoc 1978; 70: 507-9. (Pubitemid 9006640)
44. Antolak JA, Cundiff JH, Ha CS, et al. Utilization of thermoluminescentdosimetry in total skin electron beam radiotherapy of mycosis fungoides. Int J Rad Oncol Biol Phys 1998; 40: 101-8. (Pubitemid 28027573)
45. Antolak JA, Hogstrom KR. Multiple scattering theory for total skin electron beam design. Med Phys 1998; 25: 851-9. (Pubitemid 28285758)
46. el-Khatib E, Hussein S, Nikolic M, et al. Variation of electron beam uniformity with beam angulation and scatterer position for total skin irradiation with the Stanford technique. Int J Radiat Oncol Biol Phys 1995; 33: 469-74.
47. Kim TH, Pla C, Pla M, et al. Clinical aspects of a rotational total skin electron irradiation. Br J Radiol 1984; 57: 501-6. (Pubitemid 14101823)
48. van der Merwe DG. Total skin electron therapy: a technique which can be implemented on a conventional electron linear accelerator. Int J Radiat Oncol Biol Phys 1993; 27: 391-6.
49. Rosenblatt E, Kuten A, Leviov M, et al. Total skin electron irradiation in mycosis fungoides dose and fractionation considerations. Leuk Lymphoma 1998; 30: 143-51. (Pubitemid 28327263)
50. Kumar PP, Henschke UK, Nibhanupudy Jr. Problems and solutions in achieving uniform dose distribution in superficial total body electron therapy. J Natl Med Assoc 1977; 69: 645-7. (Pubitemid 9049532)
51. Desai KR, Pezner RD, Lipsett JA, et al. Total skin electron irradiation for mycosis fungoides: relationship between acute toxicities and measured dose at different anatomic sites. Int J Radiat Oncol Biol Phys 1988; 15: 641-5.
52. Wilson LD, Kacinski BM, Jones GW. Local superficial radiotherapy in the managment of minimal stage IA cutaneus T-cell lymphoma (mycosis fungoides). Int J Rad Oncol Biol Phys 1998; 40: 109-15. (Pubitemid 28027574)
53. Vloten WA, Vroome H, Noordijk EM. Total skin electron beam irradiation for cutaneus T-cell lymphoma (mycosis fungoides). Br J Dermatol 1985; 112: 697-702. (Pubitemid 15061089)
54. Trump JG, Wright KA, Evans WW, et al. High-energy electrons for the treatment of extensive superficial malignant lesions. Am J Radiol 1953; 69: 623-9.
55. Freeman CR, Suissa S, Shenouda G, et al. Clinical experience with a single field rotational total skin electron irradiation technique for cutaneous T-cell lymphoma. Radiother Oncol 1992; 24: 155-62.
56. Halberg FE, Fu KK, Weaver KA, et al. Combined total body X-ray irradiation and total skin electron beam radiotherapy with an improved technique for mycosis fungoides. Int J Rad Oncol Biol Phys 1989; 17: 427-32. (Pubitemid 19203094)
57. Total skin electron beam treatment patient leaflet. C.C.f.O.-N.F. Trust; 2008.
58. Podgorsak EB. Review of radiation oncology physics: a handbook for teachers and students. Vienna, Austria: I.A.E. Agency; 2003.
59. Podgorsak EB, Pla C, Pla M, et al. Physical aspects of a rotational total skin electron irradiation. Med Phys 1983; 10: 159-68. (Pubitemid 13121570)
60. Reynard EP, Evans MD, Devic S, et al. Rotational total skin electron irradiation with a linear accelerator. J Appl Clin Med Phys 2008; 9: 2793.
61. Marinello G, Jaffre F, Ślosarek K, et al. Total skin electron irradiation. Proceedings of 3rd seminar on treatment planning in radiotherapy in Poznan. Rep Pract Oncol Radiother 1998; 3: 19-22.
62. Ulutin HC, Beyan C, Pak Y. Total skin electron beam therapy for cutaneous T-cell lymphoma: Turkish experience with translational technique. Haematologia (Budap) 2002; 32: 397-403. (Pubitemid 36665350)
63. Wu JM, Leung SW, Wang CJ, Chui CS. Lying-on position of total skin electron therapy. Int J Radiat Oncol Biol Phys 1997; 39: 521-8.
64. Sardari D, Maleki R, Samavat H, Esmaeeli A.Measurement of depth-dose of linear accelerator and simulation by use of Geant4 computer code. Rep Pract Oncol Radiother 2010; 15: 64-8.
65. Diamantopoulos S, Platoni K, Dilvoi M, et al. Clinical implementation of total skin electron beam (TSEB) therapy: a review of the relevant literature. Phys Med 2011; 27: 62-8.
66. Horowitz YS. The theoretical and microdosimetric basis of thermoluminescence and applications to delivery. Phys Med Biol 1981; 26: 765-824. (Pubitemid 11007016)
67. HPA: A practical guide to electron dosimetry below 5 MeV for radiotherapy purposes. Hosp Phys Assoc Rep 1975; 13: 1-18.
68. Jabbari N, Barati AH, Rahmatnezhad L. Multiple-source models for electron beams of a medical linear accelerator using BEAMDP computer code. Rep Pract Oncol Radiother 2012; 17: 211-9.
69. The Cooperative Group for PET-CT in Radiotherapy Treatment Planning. Recommendations of the Spanish Societies of Radiation Oncology (SEOR), Nuclear Medicine & Molecular Imaging (SEMNiM), and Medical Physics (SEFM) on 18F-FDG PETCT for radiotherapy treatment planning. Rep Pract Oncol Radiother 2012; 17: 298-318.
70. Weaver RD, Gerbi BJ, Dusenbery KE. Evaluation of dose variation during total skin electron irradiation using thermoluminescent dosimeters. Int J Radiat Oncol Biol Phys 1995; 33: 475-8.
71. Thwaites DI, Malicki J. Physics and technology in ESTRO and in radiotherapy and oncology: past, present and into the 4th dimension. Radiother Oncol 2011; 100: 327-32.
72. Piotrowski T, Fundowicz D, Pawlaczyk M, Malicki J. Thermoluminescentdosimetry in rotary dual technique of the total skin electron irradiation. Neoplasma 2003; 50: 41-6.
73. Hogstrom KR, Ewton JR, Cundiff JH, et al. Beam delivery system and dosimetry for total skin electron irradiation at MDAH. Med Phys 1984; 11: 389.
74. ICRU Report 35. Radiation dosimetry: electron beams with energies beetwen 1 and 50 MeV. Maryland: ICRU Publ 1984.
75. Crespo RH, Domeno MM, Rodríguez MJP. Biodosimetry and assessment of radiation dose. Rep Pract Oncol Radiother 2011; 16: 131-7.
76. Malicki J. The importance of accurate treatment planning, delivery, and dose verification. Rep Pract Oncol Radiother 2012; 17: 63-5.